• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞与哮喘。I. 变应性和非变应性哮喘中的淋巴细胞亚群与活化

T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma.

作者信息

Walker C, Virchow J C, Iff T, Bruijnzeel P L, Blaser K

机构信息

Schweizerisches Institut für Allergie- und Asthmaforschung, Davos, Switzerland.

出版信息

Int Arch Allergy Appl Immunol. 1991;94(1-4):241-3.

PMID:1834580
Abstract

Abnormalities of peripheral-blood lymphocyte subsets and activation markers were detected in patients with both allergic and nonallergic asthma. Most allergic asthmatics were characterized by increased numbers of IL-2R+ helper T cells and CD23+ B cells. In contrast, nonallergic asthmatics showed increased numbers of IL-2R+ and HLA-DR+ helper and cytotoxic T cells, and a clear redistribution from naive (CD45RA+) to memory (CD45RO+) cells. The number of IL-2R+ T cells correlated with the number of CD23+ B cells in allergic asthma. These changes in the distribution and activation state of T cells suggest an active role for T cells in the pathogenesis of both allergic and nonallergic asthma.

摘要

在过敏性和非过敏性哮喘患者中均检测到外周血淋巴细胞亚群和激活标志物异常。大多数过敏性哮喘患者的特征是白细胞介素-2受体(IL-2R)阳性辅助性T细胞和CD23阳性B细胞数量增加。相比之下,非过敏性哮喘患者表现为IL-2R阳性以及人类白细胞抗原-DR(HLA-DR)阳性的辅助性和细胞毒性T细胞数量增加,并且出现从初始(CD45RA阳性)细胞到记忆(CD45RO阳性)细胞的明显重新分布。在过敏性哮喘中,IL-2R阳性T细胞数量与CD23阳性B细胞数量相关。T细胞分布和激活状态的这些变化表明T细胞在过敏性和非过敏性哮喘的发病机制中发挥着积极作用。

相似文献

1
T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma.T细胞与哮喘。I. 变应性和非变应性哮喘中的淋巴细胞亚群与活化
Int Arch Allergy Appl Immunol. 1991;94(1-4):241-3.
2
[A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].[不同类型支气管哮喘中T淋巴细胞亚群活化标志物表达的比较研究]
Ter Arkh. 1995;67(3):26-9.
3
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma.
J Immunol. 1991 Mar 15;146(6):1829-35.
4
Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage.过敏性哮喘患者和非过敏性哮喘患者在外周血及支气管肺泡灌洗中具有不同的T细胞活化模式和细胞因子产生情况。
Am Rev Respir Dis. 1992 Jul;146(1):109-15. doi: 10.1164/ajrccm/146.1.109.
5
Peripheral blood manifestations of T(H)2 lymphocyte activation in stable atopic asthma and during exercise-induced bronchospasm.稳定期特应性哮喘及运动诱发性支气管痉挛时T(H)2淋巴细胞激活的外周血表现
Ann Allergy Asthma Immunol. 1998 May;80(5):424-32. doi: 10.1016/S1081-1206(10)62996-1.
6
Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.妊娠早期人蜕膜T细胞上活化抗原CD69、HLA-DR、白细胞介素-2受体α(IL-2Rα)和IL-2Rβ的表达。
Immunology. 1992 Apr;75(4):710-2.
7
Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.特应性皮炎和支气管哮喘患儿的细胞因子产生、活化标志物及皮肤归巢受体
Pediatr Allergy Immunol. 2006 May;17(3):166-74. doi: 10.1111/j.1399-3038.2006.00390.x.
8
Differential regulation of T- and B-lymphocyte activation in severely burned patients.严重烧伤患者T淋巴细胞和B淋巴细胞激活的差异调节
J Trauma. 1991 Feb;31(2):239-46.
9
Functional analysis of human T cell subsets defined by CD45 isoform expression.通过CD45异构体表达定义的人类T细胞亚群的功能分析。
Semin Immunol. 1992 Feb;4(1):35-41.
10
Atopic asthma: differential activation phenotypes among memory T helper cells.特应性哮喘:记忆性辅助性T细胞中的不同激活表型
Clin Exp Allergy. 2001 Aug;31(8):1232-41. doi: 10.1046/j.1365-2222.2001.01146.x.

引用本文的文献

1
Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.与粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白细胞介素-5(IL-5)相比,白细胞介素-3(IL-3)对嗜酸性粒细胞进行差异性激活的基本机制
Crit Rev Immunol. 2016;36(5):429-444. doi: 10.1615/CritRevImmunol.2017020172.